State of Melanoma: An Historic Overview of a Field in Transition
作者： Vikram C. Gorantla , John M. Kirkwood
DOI: 10.1016/J.HOC.2014.02.010
关键词:
摘要: … and first noted the heritable nature of melanoma and familial atypical multiple melanoma. In … of melanoma. The discovery of the melanocortin receptor 1 (MC1R) on skin/hair phenotype …
sci-hub.se 参考文章(190)
James Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, Jean Jacques Grob, C. Lance Cowey, Christopher D. Lao, Dirk Schadendorf, Reinhard Dummer, Michael Smylie, Piotr Rutkowski, Pier F. Ferrucci, Andrew Hill, John Wagstaff, Matteo S. Carlino, John B. Haanen, Michele Maio, Ivan Marquez-Rodas, Grant A. McArthur, Paolo A. Ascierto, Georgina V. Long, Margaret K. Callahan, Michael A. Postow, Kenneth Grossmann, Mario Sznol, Brigitte Dreno, Lars Bastholt, Arvin Yang, Linda M. Rollin, Christine Horak, F. Stephen Hodi, Jedd D. Wolchok, Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. The New England Journal of Medicine. ,vol. 373, pp. 23- 34 ,(2015) , 10.1056/NEJMOA1504030
Charles M Balch, Seng-jaw Soong, Thomas Smith, Merrick I Ross, Marshall M Urist, Constantine P Karakousis, Walley J Temple, Martin C Mihm, Raymond L Barnhill, William R Jewell, Harry J Wanebo, Reneé Desmond, Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Annals of Surgical Oncology. ,vol. 8, pp. 101- 108 ,(2001) , 10.1245/ASO.2001.8.2.101
S. Mocellin, S. Pasquali, C. R. Rossi, D. Nitti, Interferon Alpha Adjuvant Therapy in Patients With High-Risk Melanoma: A Systematic Review and Meta-analysis Journal of the National Cancer Institute. ,vol. 102, pp. 493- 501 ,(2010) , 10.1093/JNCI/DJQ009
Jeffrey A. Sosman, Kevin B. Kim, Lynn Schuchter, Rene Gonzalez, Anna C. Pavlick, Jeffrey S. Weber, Grant A. McArthur, Thomas E. Hutson, Stergios J. Moschos, Keith T. Flaherty, Peter Hersey, Richard Kefford, Donald Lawrence, Igor Puzanov, Karl D. Lewis, Ravi K. Amaravadi, Bartosz Chmielowski, H. Jeffrey Lawrence, Yu Shyr, Fei Ye, Jiang Li, Keith B. Nolop, Richard J. Lee, Andrew K. Joe, Antoni Ribas, Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib The New England Journal of Medicine. ,vol. 366, pp. 707- 714 ,(2012) , 10.1056/NEJMOA1112302
Rebecca Siegel, Jiemin Ma, Zhaohui Zou, Ahmedin Jemal, Cancer statistics, 2014 CA: A Cancer Journal for Clinicians. ,vol. 64, pp. 9- 29 ,(2014) , 10.3322/CAAC.21208
Peter Gillgren, Krzysztof T Drzewiecki, Marianne Niin, Hans P Gullestad, Henrik Hellborg, Eva Månsson-Brahme, Christian Ingvar, Ulrik Ringborg, 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial The Lancet. ,vol. 378, pp. 1635- 1642 ,(2011) , 10.1016/S0140-6736(11)61546-8
E.M. Hersh, M. Del Vecchio, M.P. Brown, R. Kefford, C. Loquai, A. Testori, S. Bhatia, R. Gutzmer, R. Conry, A. Haydon, C. Robert, S. Ernst, J. Homsi, J.J. Grob, K. Kendra, S.S. Agarwala, M. Li, A. Clawson, C. Brachmann, M. Karnoub, I. Elias, M.F. Renschler, A. Hauschild, A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma Annals of Oncology. ,vol. 26, pp. 2267- 2274 ,(2015) , 10.1093/ANNONC/MDV324
John M. Kirkwood, Vernon K. Sondak, Lawrence E. Flaherty, James Moon, Michael B. Atkins, Ralph Tuthill, John A. Thompson, John T. Vetto, Frank G. Haluska, Alberto S. Pappo, Jeffrey Alan Sosman, Bruce G. Redman, Antoni Ribas, Phase III trial of high-dose interferon alpha-2b versus cisplatin, vinblastine, DTIC plus IL-2 and interferon in patients with high-risk melanoma (SWOG S0008): An intergroup study of CALGB, COG, ECOG, and SWOG. Journal of Clinical Oncology. ,vol. 30, pp. 8504- 8504 ,(2012) , 10.1200/JCO.2012.30.15_SUPPL.8504
Rodrigo R Munhoz, Alejandro Falcón González, Vanessa A Reed, Michael A Postow, Targeting immune checkpoints in melanoma: an update. Melanoma management. ,vol. 2, pp. 339- 352 ,(2015) , 10.2217/MMT.15.25
D. L. Morton, N. Mozzillo, J. F. Thompson, M. C. Kelley, M. Faries, J. Wagner, S. Schneebaum, L. Schuchter, G. Gammon, R. Elashoff, An international, randomized, phase III trial of bacillus Calmette-Guerin (BCG) plus allogeneic melanoma vaccine (MCV) or placebo after complete resection of melanoma metastatic to regional or distant sites Journal of Clinical Oncology. ,vol. 25, pp. 8508- 8508 ,(2007) , 10.1200/JCO.2007.25.18_SUPPL.8508